Stock Events

Stock Events

Adocia SA 

$8.87
68
+$0+0% Monday 16:44

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
75.87M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

21AprExpected
Q3 2023
Q1 2024
Q2 2024
Q1 2025
Q2 2025
Q4 2025
Q1 2026
-0.57
0.66
1.88
3.11
Expected EPS
-0.570067690464
Actual EPS
-0.570067690464

Financials

-62.07%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
12.1MRevenue
-7.51MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ADOIF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novo Nordisk
NVO
Mkt Cap194.57B
Novo Nordisk is a leading global healthcare company that focuses on diabetes care, where Adocia also has significant investments, making them direct competitors in the diabetes treatment market.
Sanofi
SNY
Mkt Cap110.4B
Sanofi is involved in diabetes and cardiovascular diseases treatment research, directly competing with Adocia's diabetes management products.
Lilly(Eli) &
LLY
Mkt Cap862.01B
Eli Lilly is a major player in the diabetes care market, developing insulin and other diabetes treatments that compete with Adocia's product offerings.
Merck
MRK
Mkt Cap277.02B
Merck & Co. focuses on diabetes treatment through its drug portfolio, positioning it as a competitor to Adocia in the diabetes care sector.
Astrazeneca
AZN
Mkt Cap286.4B
AstraZeneca operates in various therapeutic areas, including diabetes, where its products compete with Adocia's diabetes treatments.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol-Myers Squibb has a presence in the diabetes treatment market, making it a competitor to Adocia with its range of diabetes care products.
Novartis
NVS
Mkt Cap279.67B
Novartis AG, through its research and development in diabetes and metabolic diseases, competes with Adocia in the diabetes treatment market.
Pfizer
PFE
Mkt Cap149.77B
Pfizer is involved in the discovery, development, and manufacture of healthcare products including treatments for diabetes, competing with Adocia.
Tandem Diabetes Care
TNDM
Mkt Cap1.33B
Tandem Diabetes Care designs, develops, and commercializes products for people with insulin-dependent diabetes, directly competing with Adocia's insulin management solutions.
Insulet
PODD
Mkt Cap12.12B
Insulet Corporation, through its Omnipod Insulin Management System, competes in the insulin delivery market, directly challenging Adocia's diabetes treatment solutions.

About

There is no Profile data available for A89.SG.
Show more...
CEO
Country
France
ISIN
FR0011184241
WKN
000A1JTC2

Listings

PA
FR
ADOBS.PA
STU
DE
A89.STU
MU
DE
A89.MU
LSE
GB
0QAI.LSE

0 Comments

Share your thoughts

FAQ

What is Adocia SA stock price today?▼
The current price of ADOIF is $8.87 USD — it has increased by +0% in the past 24 hours. Watch Adocia SA stock price performance more closely on the chart.
What is Adocia SA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Adocia SA stocks are traded under the ticker ADOIF.
What is Adocia SA market cap?▼
Today Adocia SA has the market capitalization of 75.87M
What were Adocia SA earnings last quarter?▼
ADOIF earnings for the last quarter are -0.9 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Adocia SA revenue for the last year?▼
Adocia SA revenue for the last year amounts to 12.1M USD.
What is Adocia SA net income for the last year?▼
ADOIF net income for the last year is -7.51M USD.
In which sector is Adocia SA located?▼
Adocia SA operates in the Other sector.
When did Adocia SA complete a stock split?▼
Adocia SA has not had any recent stock splits.